Hypera Pharma HYPE3 Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Brazil
BOV
Hypera Pharma (HYPE3)
Hypera Pharma (HYPE3) Financials

Hypera Pharma (HYPE3)

20.20

-0.30

( -1.46% )

Updated: 11:33:37

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)
Total Revenue	2.21B	2.39B	2.58B	2.03B	2.65B	2.58B	2.3B	2.21B
Operating Income	644.04M	684.03M	686.62M	535.8M	734.13M	735.84M	512.03M	579.4M
Pre Tax Income	433.67M	442.13M	440.84M	270.02M	471.84M	474.34M	293.28M	373.81M
Net Income	455.52M	469.68M	431.74M	339.42M	504.39M	497.94M	309.37M	391.55M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	644.04M	684.03M	686.62M	535.8M	734.13M	735.84M	512.03M	579.4M
EBITDA	683.19M	727.47M	736.33M	588.74M	789.62M	797.7M	577.28M	646.82M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)	BRL (R$)
Total Revenue	4.77B	4.47B	4.47B	4.12B	4.98B	7.08B	8.97B	9.56B
Operating Income	1.83B	950.6M	1.22B	1.05B	1.28B	1.53B	2.47B	2.52B
Pre Tax Income	1.61B	998.26M	1.22B	1.06B	1.21B	1.21B	1.6B	1.51B
Net Income	1.17B	964.94M	1.13B	1.16B	1.3B	1.33B	1.7B	1.65B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	1.858	1.526	1.787	1.841	2.045	2.1	2.677	2.6
EBIT	1.82B	950.6M	1.22B	1.05B	1.28B	1.53B	2.47B	2.52B
EBITDA	1.86B	1.03B	1.31B	1.14B	1.4B	1.67B	2.64B	2.75B

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions